• Skip to main content
  • Skip to footer

GBT Pharma

Experts in OTC market access

  • Our Services
    • International Business Development
    • International Product Development
  • Our Products
    • cannaQIX
    • Klear-vol
    • Estroplus Meno Manage
    • Pediatra Suizo
    • Estroplus™
    • Phytovir®
    • Similasan®
    • Kwai
    • Kira
  • About GBT Pharma
    • Company History
  • GBT Pharma Clients
  • The GBT Pharma Team
    • Our Team in Switzerland
    • Our Team in Latin America
    • Our Team in the UK
  • News
  • Contact Us

August 2, 2017 By Heather Scott

Central America offers vast opportunities for bold OTC companies

Is seeking entry into the Central American OTC market a goal for your consumer healthcare business? Then this market insight report is for you. As published in OTC Bulletin, this detailed report reveals where the opportunities lie for companies wishing to expand in this growing market.

Comprising seven countries and with a promising growth forecast, Central America offers a host of opportunities for OTC companies. In the latest of a series of in-depth articles featured in industry title – OTC Bulletin – GBT Pharma founder Dr Gian Trepp reveals all about this enticing yet complex market.

Filed Under: News

Footer

Contact Us

Rte de la Vignettaz 25 |

1700 Fribourg |

Switzerland |

Tel: + 41 79 262 60 43

gian.trepp@gbtpharma.com

About Us

We specialize in developing international markets for our clients. As your partner in driving international growth, GBT Pharma works to quickly understand your business and its objectives.

Follow Us

  • LinkedIn

Copyright © 2025 · GBT Pharma